E-Brochure - Download Now!
A basic semen analysis is usually the first step in evaluating male fertility, but it rarely tells the whole story. When results come back inconclusive, or when a couple has faced repeated unsuccessful cycles, several more detailed tests can reveal what a standard analysis alone cannot.
A standard semen analysis measures count, motility and morphology, giving a useful idea of sperm health. What it does not capture is the genetic integrity of the sperm, underlying hormonal imbalances, or structural issues that could be affecting fertility despite an otherwise normal looking report.
This is particularly relevant for couples experiencing unexplained infertility, recurrent miscarriage, or repeated IVF or IUI failures despite normal semen parameters, since these situations often call for a more detailed investigation into what a basic analysis simply cannot detect.
This test measures the percentage of sperm with damaged genetic material, offering insight into sperm quality that count and motility alone cannot capture. It is particularly useful when semen parameters appear normal but conception has still not occurred.
While AMH is more commonly used to assess ovarian reserve in women, it can also offer insight into testicular function in men, particularly Sertoli cell activity, and is sometimes used in cases of suspected non-obstructive azoospermia to help evaluate whether sperm producing tissue is present.
A full hormone panel helps identify imbalances that can directly affect sperm production. Low testosterone, elevated FSH, or abnormal prolactin levels can all point toward specific underlying causes that a semen analysis alone would not reveal.
This imaging test examines the testicles and surrounding structures for issues such as varicocele, blockages, or structural abnormalities that could be affecting sperm production or transport, often invisible on physical examination alone.
For men with very low or absent sperm counts, genetic tests such as karyotyping or Y chromosome microdeletion analysis can identify inherited causes of infertility, which also carries important implications for future children if conception is achieved through assisted reproduction.
This test checks for antibodies that mistakenly target sperm, sometimes following infection, injury or surgery, which can significantly impair sperm function even when count and motility appear otherwise normal.
Because it comes up so often, the DFI test deserves a closer look. A 2024 study examining sperm DNA fragmentation across nearly 6,000 IVF and ICSI cycles found that a DFI below 15% is generally considered normal, 15 to 30% is considered borderline, and above 30% is considered high, with miscarriage rates significantly higher in both the borderline and high DFI groups compared to those with normal results.
High DNA fragmentation does not necessarily mean conception is impossible, but it can affect embryo development and increase the risk of miscarriage, which is why identifying it matters for planning the right treatment approach, whether that involves lifestyle changes, antioxidant therapy, or selecting a specific assisted reproduction technique suited to the result.
A basic semen analysis is a useful starting point, but it rarely tells the complete story behind male fertility challenges. Understanding which additional tests are relevant to your specific situation can uncover answers a standard report simply cannot provide.
Goral Gandhi offers comprehensive male fertility evaluation, including DNA fragmentation testing and hormone analysis, to help identify the real cause behind fertility challenges and guide the right treatment approach. Book a consultation to get a complete picture of your fertility health.
